Articles Tagged: Ovarian Cancer


J&J’s $5.5 Billion Talc Deal Signals a New Phase in Ovarian-Cancer Litigation

Johnson Johnson has announced a proposed $5.5 billion global resolution aimed at settling tens of thousands of lawsuits alleging its talcum powder products caused ovarian cancer, a major development in one of the country’s most closely watched mass torts.